Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
330
datasets available to search
ShareScore release 0.9.0
Dataset results
330 results for “medical care”
Improving Medical Training for the Care of Chronic Conditions
ClinicalTrials.gov study NCT00676208. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
ClinicalTrials.gov study NCT02444988. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Addressing Antihypertensive Medication Adherence Through EHR-enabled Teamlets in Primary Care
ClinicalTrials.gov study NCT05349422. IPD Sharing: YES. Countries: 1. Publications: 4.
Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)
ClinicalTrials.gov study NCT05103332. IPD Sharing: YES. Countries: 8. Publications: 1.
Isotonic Solutions and Major Adverse Renal Events Trial in the Non-Medical Intensive Care Unit (SMART-SURG)
ClinicalTrials.gov study NCT02547779. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Preparing Spanish-speaking Older Adults for Advance Care Planning and Medical Decision Making (PREPARE)
ClinicalTrials.gov study NCT02072941. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Chiropractic Manipulation and Medical Care for Low Back Pain
ClinicalTrials.gov study NCT01211613. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Medical Education to Improve Diabetes Care and Outcomes in Hospitalized Patients
ClinicalTrials.gov study NCT07108426. IPD Sharing: NO. Countries: 1. Publications: 9.
Data from: Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in primary care: an interrupted time series analysis
Open the record for dataset details and reuse information.
Data from: Sustainability of professionals' adherence to clinical practice guidelines in medical care: a systematic review
Objectives: To evaluate (1) the state of the art in sustainability research and (2) the outcomes of professionals' adherence to guideline recommendations in medical practice. Design: Systematic review. Data sources: Searches were conducted until August 2015 in MEDLINE, CINAHL, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL) and the Guidelines International Network (GIN) library. A snowball strategy, in which reference sections of other reviews and of included papers were searched, was used to identify additional papers. Eligibility criteria: Studies needed to be focused on sustainability and on professionals' adherence to clinical practice guidelines in medical care. Studies had to include at least 2 measurements: 1 before (PRE) or immediately after implementation (EARLY POST) and 1 measurement longer than 1 year after active implementation (LATE POST). Results: The search retrieved 4219 items, of which 14 studies met the inclusion criteria, involving 18 sustainability evaluations. The mean timeframe between the end of active implementation and the sustainability evaluation was 2.6 years (minimum 1.5–maximum 7.0). The studies were heterogeneous with respect to their methodology. Sustainability was considered to be successful if performance in terms of professionals' adherence was fully maintained in the late postimplementation phase. Long-term sustainability of professionals' adherence was reported in 7 out of 18 evaluations, adherence was not sustained in 6 evaluations, 4 evaluations showed mixed sustainability results and in 1 evaluation it was unclear whether the professional adherence was sustained. Conclusions: (2) Professionals' adherence to a clinical practice guideline in medical care decreased after more than 1 year after implementation in about half of the cases. (1) Owing to the limited number of studies, the absence of a uniform definition, the high risk of bias, and the mixed results of studies, no firm conclusion about the sustainability of professionals' adherence to guidelines in medical practice can be drawn.
Data from: Medical expenditure for chronic diseases in Mexico: the case of selected diagnoses treated by the largest care providers
Background: Chronic diseases (CD) are a public health emergency in Mexico. Despite concern regarding the financial burden of CDs in the country, economic studies have focused only on diabetes, hypertension, and cancer. Furthermore, these estimated financial burdens were based on hypothetical epidemiology models or ideal healthcare scenarios. The present study estimates the annual expenditure per patient and the financial burden for the nine most prevalent CDs, excluding cancer, for each of the two largest public health providers in the country: the Ministry of Health (MoH) and the Mexican Institute of Social Security (IMSS). Methods: Using the Mexican National Health and Nutrition Survey 2012 (ENSANUT) as the main source of data, health services consumption related to CDs was obtained from patient reports. Unit costs for each provided health service (e.g. consultation, drugs, hospitalization) were obtained from official reports. Prevalence data was obtained from the published literature. Annual expenditure due to health services consumption was calculated by multiplying the quantity of services consumed by the unit cost of each health service. Results: The most expensive CD in both health institutions was chronic kidney disease (CKD), with an annual unit cost for MoH per patient of US$ 8,966 while for IMSS the expenditure was US$ 9,091. Four CDs (CKD, arterial hypertension, type 2 diabetes, and chronic ischemic heart disease) accounted for 88% of the total CDs financial burden (US$ 1.42 billion) in MoH and 85% (US$ 3.96 billion) in IMSS. The financial burden of the nine CDs analyzed represents 8% and 25% of the total annual MoH and IMSS health expenditure, respectively. Conclusions/Significance: The financial burden from the nine most prevalent CDs, excluding cancer, is already high in Mexico. This finding by itself argues for the need to improve health promotion and disease detection, diagnosis, and treatment to ensure CD primary and secondary prevention. If the status quo remains, the financial burden could be higher.
Regional Variation in the Primary Medical Care of Northern Germany
ClinicalTrials.gov study NCT02558322. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Early Directed Physical Therapy in the Management of Mechanically Ventilated Patients in a Medical Intensive Care Unit
ClinicalTrials.gov study NCT00322010. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effects of Point-of-Care Ultrasound in Multidisciplinary Medical Wards
ClinicalTrials.gov study NCT06529315. IPD Sharing: NO. Countries: 1. Publications: 17.
Comprehensive Care of Children With Medical Complexity
ClinicalTrials.gov study NCT01834456. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Medical Assistant Health Coaching in Primary Care for Patients With Chronic Conditions
ClinicalTrials.gov study NCT01220336. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Live Stream of Ultrasound in Prehospital Medical Care
ClinicalTrials.gov study NCT04612816. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Transcranial Direct Current Stimulation (tDCS) Cost-utility-analysis in Medical Care on Depressive Episode With One Drug Therapy Failure.
ClinicalTrials.gov study NCT03758105. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties
ClinicalTrials.gov study NCT04448015. IPD Sharing: NO. Countries: 1. Publications: 1.
Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
ClinicalTrials.gov study NCT02868983. IPD Sharing: YES. Countries: 1. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.